Net Profit & Net Margin
RSCH PT. Charlie Hospital Semarang Tbk
895.700,00
338
-8 (-2,00%)
2019
n/a
2020
n/a
2021
n/a
2022
n/a
2023
-1.111 (-2.64%)
IRRA PT. Itama Ranoraya Tbk
636.300,00
422
-6 (-1,00%)
2019
33.205 (11.79%)
2020
60.521 (10.73%)
2021
112.155 (8.5%)
2022
48.004 (6.37%)
2023
5.198 (0.75%)
SURI PT. Maja Agung Latexindo Tbk
563.759,00
89
+1 (+1,12%)
2019
n/a
2020
n/a
2021
n/a
2022
10.226 (10.96%)
2023
5.468 (6.69%)
LABS PT. UBC Medical Indonesia Tbk
513.500,00
130
-3 (-2,00%)
 
IKPM PT. Ikapharmindo Putramas Tbk
458.228,00
272
-4 (-1,45%)
2019
n/a
2020
n/a
2021
n/a
2022
16.577 (4.16%)
2023
15.337 (3.48%)
PEVE PT. Penta Valent Tbk
430.811,00
244
+2 (+1,00%)
2019
4.983 (0.35%)
2020
269 (0.02%)
2021
19.276 (1.08%)
2022
23.546 (1.1%)
2023
36.171 (1.46%)
HALO PT. Haloni Jane Tbk
367.251,00
65
+1 (+2,00%)
2019
n/a
2020
n/a
2021
n/a
2022
n/a
2023
16.996 (7.35%)
DGNS PT. Diagnos Laboratorium Utama Tbk
297.500,00
228
+2 (+0,89%)
2019
n/a
2020
52.686 (28.76%)
2021
64.303 (21.28%)
2022
12.664 (6.57%)
2023
-13.655 (-9.37%)
PEHA PT. Phapros Tbk
250.320,00
298
+2 (+1,00%)
2019
102.033 (9.23%)
2020
7.154 (0.73%)
2021
11.070 (1.05%)
2022
28.069 (2.4%)
2023
5.959 (0.59%)
PRIM PT. Royal Prima Tbk
195.943,00
58
-1 (-1,70%)
2019
2.396 (1.38%)
2020
38.169 (14.65%)
2021
75.433 (12.57%)
2022
21.589 (8.24%)
2023
-2.746 (-1.03%)
MMIX PT. Multi Medika Internasional Tbk
177.616,00
76
-2 (-2,56%)
2019
n/a
2020
352 (23.75%)
2021
10.331 (25.52%)
2022
23.668 (13.52%)
2023
16.512 (9.43%)
MEDS PT. Hetzer Medical Indonesia Tbk
78.125,00
50
0 (0%)
2019
n/a
2020
n/a
2021
n/a
2022
237 (0.63%)
2023
-3.570 (-15.71%)
INAF PT. Indofarma Tbk
0
0
0 (0%)
2019
7.961 (0.59%)
2020
27 (0%)
2021
-37.580 (-1.29%)
2022
-428.462 (-37.45%)
2023
-720.993 (-137.7%)
SCPI PT. Organon Pharma Indonesia Tbk
0
0
0 (0%)
2019
112.652 (6.12%)
2020
218.362 (7.55%)
2021
118.691 (5.5%)
2022
174.782 (7.47%)
2023
187.701 (6.83%)